This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Tesla and Nike have been highlighted as Zacks Bull and Bear of the Day
by Zacks Equity Research
Tesla and Nike are part of the Zacks Bull and Bear of the Day article.
Buy, Sell or Hold Medical Properties? Key Tips Ahead of Q3 Earnings
by Rohit Vasant Fatarpekar
MPW's Q3 earnings are likely to have been hurt by exposure to troubled operators and high interest expenses.
Ventas' Q3 FFO Meet Estimates on Higher Same-Store NOI, View Raised
by Zacks Equity Research
VTR's Q3 results reflect a year-over-year rise in revenues. The total property same-store NOI improves on strong performance across the business segments.
Here's What Key Metrics Tell Us About Ventas (VTR) Q3 Earnings
by Zacks Equity Research
Although the revenue and EPS for Ventas (VTR) give a sense of how its business performed in the quarter ended September 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Ventas (VTR) Q3 FFO Match Estimates
by Zacks Equity Research
Ventas (VTR) delivered FFO and revenue surprises of 0% and 2.30%, respectively, for the quarter ended September 2024. Do the numbers hold clues to what lies ahead for the stock?
Medical Properties Stock Down 3% in 3 Months: Time to Buy or Red Flag?
by Rohit Vasant Fatarpekar
Despite strong healthcare industry fundamentals, investors seem pessimistic about MPW due to stock sale news, dividend pay cut and southward revision of FFO estimates.
Welltower's Q3 FFO Beats Estimates, Same-Store NOI Rises Y/Y
by Zacks Equity Research
WELL's Q3 results reflect higher same-store net operating income for the senior housing operating portfolio, driven by strong revenue per occupied room.
What's in Store for Federal Realty in This Earnings Season?
by Zacks Equity Research
FRT's third-quarter results are likely to benefit from the healthy demand for its retail assets, though higher interest expenses may dampen the results.
SBA Communications' Q3 AFFO Meets Estimates, Revenues Fall Y/Y
by Zacks Equity Research
SBAC's Q3 results reflect marginal improvement in domestic cash site-leasing revenues with increasing carrier activity. Lower site development revenues hurt.
American Tower Gears Up for Q3 Earnings: What You Can Expect
by Zacks Equity Research
AMT's Q3 earnings are likely to have been hurt by high interest expenses and elevated churn despite solid demand for its communication real estate portfolio.
Stay Ahead of the Game With Ventas (VTR) Q3 Earnings: Wall Street's Insights on Key Metrics
by Zacks Equity Research
Get a deeper insight into the potential performance of Ventas (VTR) for the quarter ended September 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
What's in the Offing for Ventas Stock This Earnings Season?
by Zacks Equity Research
VTR's Q3 earnings are likely to have benefited from favorable SHOP operating trends, healthy demand for life-science real estate assets and accretive investments.
Healthpeak's Q3 FFO Beats Estimates, Same-Store NOI Rises
by Zacks Equity Research
DOC's Q3 FFO tops estimates. Results reflect a year-over-year rise in revenues and total merger-combined same-store cash (adjusted) NOI.
Key Factors to Impact Public Storage Stock in Q3 Earnings
by Zacks Equity Research
PSA's Q3 results are likely to reflect gains from high brand value and solid presence in key cities, though low demand and high interest expenses remain concerns.
Extra Space Storage to Post Q3 Earnings: What's in the Cards?
by Zacks Equity Research
While EXR's Q3 results are likely to reflect gains from high brand value and a solid presence in key cities, lower new customer rates remain a concern.
Welltower Stock to Report Q3 Earnings: What's in the Cards?
by Zacks Equity Research
WELL's Q3 earnings are likely to have benefitted from the rise in the aging population and its high healthcare expenditure. Yet, high interest expenses are a concern.
CTO Realty Growth to Report Q3 Earnings: What's in Store?
by Zacks Equity Research
Healthy demand for shopping centers and a diverse tenant base are likely to have benefited CTO's Q3 earnings despite rising e-commerce adoption and high interest expenses.
Digital Realty to Post Q3 Earnings: What's in the Cards for the Stock?
by Zacks Equity Research
DLR's Q3 earnings may have gained from solid data center demand and acceleration in digital transformation strategies. However, high interest expenses are a concern.
What's in the Cards for Healthpeak Properties This Earnings Season?
by Zacks Equity Research
DOC's Q3 earnings are likely to have benefited from rising healthcare spending and the aging population. However, higher interest expenses may have hurt it.
Ventas Stock Rises 48.9% in Six Months: What You Should Know
by Zacks Equity Research
VTR is poised to gain from a favorable demand in senior housing, backed by an expected rise in senior citizens' population.
Is SPDR Portfolio S&P 500 High Dividend ETF (SPYD) a Strong ETF Right Now?
by Zacks Equity Research
Smart Beta ETF report for SPYD
Ventas Secures Agreements With Kindred & ScionHealth for 23 LTACs
by Zacks Equity Research
To improve patient care facilities, VTR announces reaching an agreement with Kindred and ScionHealth regarding 23 long-term acute care hospitals.
Should SPDR Portfolio S&P 500 High Dividend ETF (SPYD) Be on Your Investing Radar?
by Zacks Equity Research
Style Box ETF report for SPYD
Here's Why You Should Retain Ventas Stock in Your Portfolio Now
by Zacks Equity Research
Rising healthcare spending and aging population aid Ventas' senior housing operating portfolio. However, tenant concentration and high interest rates are risks.
Ventas (VTR) Stock Rises 34.1% in Six Months: Here's How
by Zacks Equity Research
Ventas (VTR) is poised to gain from a favorable demand in senior housing, backed by an expected rise in senior citizens' population despite the high interest rates environment.